• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

可降解聚合物颗粒内部包封的格列齐特因侵蚀而实现可控释放。

Erosion induced controllable release of gliclazide encapsulated inside degradable polymeric particles.

作者信息

Zhao Yue, Chen Wenna, Cai Qing, Wang Shenguo, Bo Jun, Wu Chi

机构信息

The Open Laboratory of Bond-selective Chemistry, Department of Chemical Physics, University of Science and Technology of China, Hefei, Anhui, 230026, China.

出版信息

Macromol Biosci. 2004 Mar 15;4(3):308-13. doi: 10.1002/mabi.200300061.

DOI:10.1002/mabi.200300061
PMID:15468221
Abstract

The microphase inversion of water-insoluble poly(L-lactide), "poly[(L-lactide)-co-glycolide] and polylactide-block-poly(ethylene oxide)-block-polylactide from THF to water can result in narrowly distributed stable particles. Gliclazide, a commercial drug, can be encapsulated inside during the process. The formation and degradation of such particles was studied by laser light scattering. In comparison with the corrosion of a bulk material, the degradation of each particle is so fast that we only detect the decrease of the particle number, not the corrosion of individual particles. Therefore, the degradation is a "one-by-one" random process, just like the chemical reaction of molecules in solution. The disappearing rate of the particle number is nearly independent of time, ideal for the controlled release of drugs encapsulated inside. The amount of encapsulated gliclazide depends on the copolymer's hydrophobicity (composition), while the releasing rate mainly is, directly related to the disappearing rate of the particles. The correlation between the fluorescence intensity and the degradation was used to study the kinetics of gliclazide releasing. The releasing pattern is controllable with a proper choice of the drug loading, copolymer composition, pH and temperature.

摘要

水不溶性聚(L-丙交酯)、聚[(L-丙交酯)-共-乙交酯]以及聚丙交酯-嵌段-聚(环氧乙烷)-嵌段-聚丙交酯从四氢呋喃到水的微相转变可产生分布狭窄的稳定颗粒。商业药物格列齐特在该过程中可被包封在内部。通过激光散射研究了此类颗粒的形成与降解。与块状材料的腐蚀相比,每个颗粒的降解速度极快,以至于我们只能检测到颗粒数量的减少,而无法检测到单个颗粒的腐蚀。因此,降解是一个“逐个”的随机过程,就如同溶液中分子的化学反应。颗粒数量的消失速率几乎与时间无关,这对于包封在内部的药物的控释来说非常理想。包封的格列齐特的量取决于共聚物的疏水性(组成),而释放速率主要直接与颗粒的消失速率相关。利用荧光强度与降解之间的相关性来研究格列齐特释放的动力学。通过适当选择药物载量、共聚物组成、pH值和温度,释放模式是可控的。

相似文献

1
Erosion induced controllable release of gliclazide encapsulated inside degradable polymeric particles.可降解聚合物颗粒内部包封的格列齐特因侵蚀而实现可控释放。
Macromol Biosci. 2004 Mar 15;4(3):308-13. doi: 10.1002/mabi.200300061.
2
Formation and degradation of poly(D,L-lactide) nanoparticles and their potential application as controllable releasing devices.
Macromol Biosci. 2004 Sep 16;4(9):901-6. doi: 10.1002/mabi.200400072.
3
A novel asymmetric membrane osmotic pump capsule with in situ formed delivery orifices for controlled release of gliclazide solid dispersion system.一种新型非对称膜渗透泵胶囊,具有原位形成的释药孔,用于格列齐特固体分散体系统的控释。
Int J Pharm. 2016 Jun 15;506(1-2):340-50. doi: 10.1016/j.ijpharm.2016.04.061. Epub 2016 Apr 27.
4
On the design of in situ forming biodegradable parenteral depot systems based on insulin loaded dialkylaminoalkyl-amine-poly(vinyl alcohol)-g-poly(lactide-co-glycolide) nanoparticles.基于载胰岛素的二烷基氨基烷基胺-聚乙烯醇-g-聚(丙交酯-共-乙交酯)纳米颗粒的原位形成可生物降解肠胃外长效注射系统的设计
J Control Release. 2007 Nov 6;123(2):131-40. doi: 10.1016/j.jconrel.2007.08.004. Epub 2007 Aug 16.
5
Controlling of systemic absorption of gliclazide through incorporation into alginate beads.通过将格列齐特包埋于海藻酸钠微球中来控制其全身吸收。
Int J Pharm. 2007 Aug 16;341(1-2):230-7. doi: 10.1016/j.ijpharm.2007.03.047. Epub 2007 Apr 5.
6
Degradation behaviour of microspheres prepared by spray-drying poly(D,L-lactide) and poly(D,L-lactide-co-glycolide) polymers.通过喷雾干燥聚(D,L-丙交酯)和聚(D,L-丙交酯-共-乙交酯)聚合物制备的微球的降解行为。
Int J Pharm. 2006 Dec 1;326(1-2):139-47. doi: 10.1016/j.ijpharm.2006.07.030. Epub 2006 Jul 22.
7
Swelling behavior of cross-linked dextran hydrogels and preliminary Gliclazide release behavior.
Int J Biol Macromol. 2016 Dec;93(Pt A):978-987. doi: 10.1016/j.ijbiomac.2016.09.075. Epub 2016 Sep 21.
8
Fabrication of Second Generation Smarter PLGA Based Nanocrystal Carriers for Improvement of Drug Delivery and Therapeutic Efficacy of Gliclazide in Type-2 Diabetes Rat Model.第二代智能 PLGA 纳米晶载体的制备用于改善格列齐特在 2 型糖尿病大鼠模型中的药物传递和治疗效果。
Sci Rep. 2019 Nov 22;9(1):17331. doi: 10.1038/s41598-019-53996-4.
9
Gastrointestinal transition and anti-diabetic effect of Isabgol husk microparticles containing gliclazide.含格列齐特的亚麻籽壳微粒的胃肠道转运及抗糖尿病作用
Int J Biol Macromol. 2014 May;66:15-25. doi: 10.1016/j.ijbiomac.2014.02.014. Epub 2014 Feb 14.
10
Effect of gliclazide immobilization into layered double hydroxide on drug release.将格列齐特固定于层状双氢氧化物对药物释放的影响。
Eur J Pharm Biopharm. 2009 Oct;73(2):285-91. doi: 10.1016/j.ejpb.2009.06.007. Epub 2009 Jun 17.